Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Vishwanath Lingappa?

Vishwanath R. Lingappa

Chief Technology Officer and CoCEO

Prosetta Antiviral Inc

HQ Phone:  (415) 346-8866

Direct Phone: (415) ***-****direct phone

Email: v***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Prosetta Antiviral Inc

670 5Th Street

San Francisco, California,94107

United States

Company Description

Prosetta is a 13-year-old biotechnology company that is dedicated to the discovery, development and commercialization of innovative and cost-effective human and animal treatments and therapeutics. Prosetta applies its proprietary approach to drug discovery, ba... more.

Find other employees at this company (45)

Web References(31 Total References)


Business and Scientific Advisory Board | Akonni Biosystems

www.akonni.com [cached]

Vishwanath R. Lingappa, M.D., Ph.D.
An emeritus professor of Physiology at the University of California San Francisco, Dr. Lingappa is Chief Technology Officer and CoCEO of Prosetta Bioconformatics.


www.prosetta.com

Vishwanath R. Lingappa, MD, PhD
Chief Technology Officer and Co-CEO and Member of the Board of Directors, Prosetta Antiviral, Inc. Vishwanath R. Lingappa is currently Chief Technology Officer and CoCEO of Prosetta Antiviral, Inc., in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received the B.A. degree from Swarthmore College in 1975, the Ph.D. degree from The Rockefeller University in 1979, and the M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory. At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received the Ph.D. degree under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).


www.prosetta.com

Vishwanath R. Lingappa, MD, PhD
Chief Technology Officer and Co-CEO and Member of the Board of Directors, Prosetta Antiviral, Inc. Vishwanath R. Lingappa is currently Chief Technology Officer and CoCEO of Prosetta Antiviral, Inc, in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received the B.A. degree from Swarthmore College in 1975, the Ph.D. degree from The Rockefeller University in 1979, and the M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory. At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received the Ph.D. degree under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).


www.vipragen.com

Prof. Vishwanath R. Lingappa, MD, PhD
Vishwanath R. Lingappa is currently Chief Technology Officer and Co-CEO of Prosetta Antiviral, Inc, in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received a B.A. degree from Swarthmore College in 1975, a Ph.D. degree from The Rockefeller University in 1979, and a M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory. At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received Ph.D. degrees under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).


Prosetta Antiviral, Inc. - Corporate Management

www.prosetta.com [cached]

Vishwanath R. Lingappa, MD, PhD
Chief Technology Officer and Co-CEO and Member of the Board of Directors, Prosetta Antiviral, Inc. Vishwanath R. Lingappa is currently Chief Technology Officer and CoCEO of Prosetta Antiviral, Inc, in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received the B.A. degree from Swarthmore College in 1975, the Ph.D. degree from The Rockefeller University in 1979, and the M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory. At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received the Ph.D. degree under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory